CHU Saint Etienne
Saint-Etienne, 42000, France
Location status: Recruiting
Location contact
Jean-Philippe KLEIN, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06529224
In 2021, the revision of bioethics laws opened the door to elective egg freezing. This gives women, between their 29th and 37th birthdays, the opportunity to freeze their eggs in order to combat age decline fertility. However, communication about this new possibility has remained limited both toward women and their health professional.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Saint-Etienne, 42000, France
Location status: Recruiting
Jean-Philippe KLEIN, MD
PRINCIPAL_INVESTIGATOR
Thus, the hypothesize of this study is that these professionals, namely physicians, gynecologists and midwives, are insufficiently aware of age-related fertility decline and unaware of the possibility of elective egg freezing.
This multicenter observational cross-sectional study whose objective will be:
This study will provide valuable knowledge on the perception of elective egg freezing by health professionals, determine their training needs and motivate new information campaigns on this subject.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An online questionnaire will be distributed in electronic format to all the healthcare professionals concerned.
Time frame: Day 1
Analysis questionnaire results.
Time frame: Day 1
Analysis questionnaire results.
Time frame: Day 1
Analysis questionnaire results.
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire de Saint Etienne
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05330130
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT06686537
Body Weight, Female Urogenital Diseases
Aurora, Colorado, United States
View Trial DetailsNCT07542600
Female Infertility, Female Urogenital Diseases
Františkovy Lázně, Carlsbad Region, Czechia
View Trial DetailsNCT03496636
Female Infertility, Female Urogenital Diseases
Pittsburgh, Pennsylvania, United States
View Trial Details